Cancer immunotherapy
is a powerful treatment strategy that mobilizes
the immune system to fight disease. Cancer vaccination is one form
of cancer immunotherapy, where spatiotemporal control of the delivery
of tumor-specific antigens, adjuvants, and/or cytokines has been key
to successfully activating the immune system. Nanoscale materials
that take advantage of chemistry to control the nanoscale structural
arrangement, composition, and release of immunostimulatory components
have shown significant promise in this regard. In this Outlook, we
examine how the nanoscale structure, chemistry, and composition of
immunostimulatory compounds can be modulated to maximize immune response
and mitigate off-target effects, focusing on spherical nucleic acids
as a model system. Furthermore, we emphasize how chemistry and materials
science are driving the rational design and development of next-generation
cancer vaccines. Finally, we identify gaps in the field that should
be addressed moving forward and outline future directions to galvanize
researchers from multiple disciplines to help realize the full potential
of this form of cancer immunotherapy through chemistry and rational
vaccinology.